Market Overview

UBS Maintains Neutral on Eli Lilly and Company, Raises PT to $51.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for LLY

DateFirmActionFromTo
Dec 2014Morgan StanleyUpgradesUnderweightOverweight
Dec 2014JefferiesMaintainsHold
Oct 2014Argus ResearchMaintainsBuy

View More Analyst Ratings for LLY
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (LLY)

Around the Web, We're Loving...

Get Benzinga's Newsletters